We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Female reproductive health
- Sexually transmitted infections (STIs) in women
- HIV in women
- Human sperm penetrating the zona pellucida of an egg and 3-month fetus
- Outline
- FRT structure: Upper and lower tract
- FRT environment: Upper and lower tract
- Mucosal immune system throughout the human FRT
- Levels of protection in the FRT
- Master regulator: Sex hormones
- FRT immune responses changes through the life cycle
- Microbiome
- The microbiome consists of bacterial species
- The viral species in the human microbiome: The virome
- The fungal species in the human microbiome: The mycobiome
- The hostile vagina
- Vaginal microbiome changes through life cycle
- Factors affecting vaginal microbiome
- Interventions to improve vaginal microbiome
- Methods
- Sampling the FRT
- In vitro approaches
- Ex vivo approaches
- Ex vivo approaches: Mattek
- Ex vivo approaches: Organoids
- Ex vivo approaches: Organ on a chip
- In vivo approaches
- In vivo approaches: Human
- Methods to study the human model
- FRT secretions/fluids
- Collection methods
- Considerations in sample collection
- Sample type and assay method comparison
- FRT cells
- FRT cells: Upper vs. lower tract
- FRT cells and hormones
- Flow cytometry
- FRT sampling during pregnancy
- Vaginal microbiome
- Systems biology approaches
- Single cell profiling
- Inherent variability of the human model
- Variability due to menstrual cycle
- Challenges and considerations
- Financial disclosures
Topics Covered
- Female reproductive health
- Female reproductive tract (FRT)
- Mucosal immune system throughout FRT
- FRT microbiome
- Sampling the FRT
- In vitro approaches
- Ex vivo approaches
- In vivo approaches
- Collection methods
- FRT cells study assays
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Ghosh, M. (2026, June 30). Methods to study the female reproductive tract: focus on the immune system [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved August 19, 2026, from https://doi.org/10.69645/ICPY7640.Export Citation (RIS)
Publication History
- Published on June 30, 2026
Financial Disclosures
- For “Menopause & Ovarian Aging: Aging and Menopause” and "Menopause & Ovarian Aging: Aging of the Female Reproductive Tract", there are no commercial/financial matters to disclose. For “Methods to Study the Female Reproductive Tract: Focus on the Immune System”, some unpublished data shown were funded through “Genital Health of Trans-men on Testosterone”, NIH R21AI157927-02 (MG) Data was prepared by Janja Kovacic (Ghosh Lab).
Other Talks in the Series: The Female Reproductive System: from Basic Science to Fertility Treatments
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everyone.
I'm Dr. Mimi Ghosh,
an associate professor at
the Department of
Epidemiology at
the Milken Institute
School of Public Health
in the George
Washington University.
Today, I will talk to you
about the methods to study
the female reproductive tract
with a focus on
the immune system.
0:19
Why is it important to study
the female reproductive tract,
which I will also refer
to as FRT sometimes?
It's important to study
the female reproductive
tract because
more than 20
pathogens can infect
the female reproductive tract,
and sexually transmitted
infections, or STIs,
have a direct impact on
sexual and reproductive health
through stigmatization,
infertility, cancers, and
pregnancy complications.
A major issue is drug resistance
to all the STIs that
actually have treatments,
and this is a big
burden worldwide.
0:53
In women, more than
one million STIs
can be acquired
every day worldwide.
Four of the STIs
that are curable,
chlamydia, gonorrhea,
syphilis, and trichomonas,
each year, there's an estimated
374 million new infections.
More than 500 million people
15-49 years are
estimated to have
a genital infection with
herpes simplex virus.
Then human papillomavirus
infection is also
a very serious one
which has been
associated with infertility
and cervical cancer.
1:25
HIV in women is also
a very big problem.
Thirty-nine million
people globally
were living with HIV in 2022,
and of them 53% were
women and girls,
so HIV does affect women
disproportionately.
Globally, 46% of all
new HIV infections
were among women
and girls in 2022.
In sub-Saharan Africa,
adolescent girls and young women
accounted for more than
77% of new infections
among young people
aged 15-24 years,
and the young girls
in that age range,
the 15-24 range, were
more than three times
as likely to acquire HIV than
the young boys in
that same age range.
To understand the mechanisms by